Literature DB >> 24210807

Endoscopic transnasal resection of ameloblastoma with intracranial extension.

Royce W Woodroffe1, Taylor J Abel2, Aaron Fletcher3, Andrew Grossbach1, Douglas J Van Daele3, Erin O'Brien3, Jeremy D W Greenlee4.   

Abstract

Ameloblastoma is a rare odontogenic tumor with characteristics of epithelial tissue that produces enamel for the developing tooth. This lesion is generally considered benign, but has malignant forms that invade locally and metastasize. We present a 60-year-old man with maxillary ameloblastoma that after multiple recurrences developed intracranial extension with dural involvement of the middle cranial fossa and was treated by endoscopic transnasal resection followed by radiation therapy. Our technique and intraoperative findings are described with a review of the literature on intracranial ameloblastoma. This patient represents a unique account of endoscopic transnasal resection being utilized in the treatment of intracranial extension of ameloblastoma and demonstrates potential for application in similar cases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Approach; Dental tumor; Endoscopy; Skull base

Mesh:

Year:  2013        PMID: 24210807     DOI: 10.1016/j.jocn.2013.07.013

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

Review 1.  Ameloblastoma and Intracranial Involvement: The Current Challenge of the Radical Surgical Treatment. Comprehensive Review of the Literature and Institution experience.

Authors:  Daniele Armocida; Luigi Valentino Berra; Resi Pucci; Andrea Battisti; Marco Della Monaca; Valentino Valentini; Antonio Santoro
Journal:  J Maxillofac Oral Surg       Date:  2021-09-24

2.  Pure endoscopic transsphenoidal treatment of skull base ameloblastoma with intracranial extension: Case report and literature review.

Authors:  Tiago Silva Holanda Ferreira; Isnara Mara Freitas Pimentel; Lucas Alverne Freitas de Albuquerque; Jackson A Gondim
Journal:  Surg Neurol Int       Date:  2020-08-01

3.  Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation.

Authors:  Gustavo S Fernandes; Daniel M Girardi; João Paulo G Bernardes; Felipe P Fonseca; Eduardo R Fregnani
Journal:  BMC Cancer       Date:  2018-09-12       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.